On Monday, CVS Health Corp (NYSE: CVS) opened higher 5.38% from the last session, before settling in for the closing price of $53.19. Price fluctuations for CVS have ranged from $52.71 to $83.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 13.36% over the past five years. Company’s average yearly earnings per share was noted -36.57% at the time writing. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
Let’s look at the performance matrix of the company that is accounted for 300000 employees. In terms of profitability, gross margin is 14.05%, operating margin of 2.55%, and the pretax margin is 1.83%.
CVS Health Corp (CVS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of CVS Health Corp is 0.19%, while institutional ownership is 82.27%. The most recent insider transaction that took place on May 02 ’24, was worth 53,879. In this transaction Director of this company bought 1,000 shares at a rate of $53.88, taking the stock ownership to the 21,630 shares. Before that another transaction happened on May 02 ’24, when Company’s Director bought 9,181 for $54.49, making the entire transaction worth $500,294. This insider now owns 9,356 shares in total.
CVS Health Corp (CVS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -36.57% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Check out the current performance indicators for CVS Health Corp (CVS). In the past quarter, the stock posted a quick ratio of 0.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.18. Likewise, its price to free cash flow for the trailing twelve months is 40.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.94, a number that is poised to hit 1.14 in the next quarter and is forecasted to reach 6.44 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
CVS Health Corp (NYSE: CVS) saw its 5-day average volume 13.64 million, a positive change from its year-to-date volume of 11.37 million. As of the previous 9 days, the stock’s Stochastic %D was 17.35%. Additionally, its Average True Range was 2.17.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 22.14%, which indicates a significant decrease from 31.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.93% in the past 14 days, which was higher than the 36.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.19, while its 200-day Moving Average is $63.30. Nevertheless, the first resistance level for the watch stands at $57.40 in the near term. At $58.76, the stock is likely to face the second major resistance level. The third major resistance level sits at $60.73. If the price goes on to break the first support level at $54.07, it is likely to go to the next support level at $52.10. The third support level lies at $50.74 if the price breaches the second support level.
CVS Health Corp (NYSE: CVS) Key Stats
There are currently 1,258,408K shares outstanding in the company with a market cap of 68.10 billion. Presently, the company’s annual sales total 357,776 M according to its annual income of 8,344 M. Last quarter, the company’s sales amounted to 95,428 M and its income totaled 87,000 K.
